期刊文献+

原发性肝细胞癌不同部位肿瘤浸润性淋巴细胞得率及成活率 被引量:5

The acquired number and activity of tumor infiltrating lymphocytes in different places in hepatocellular carcinoma tissue
下载PDF
导出
摘要 目的探讨原发性肝细胞癌(primaryhepatocelularcarcinoma,PHCC)肿瘤组织不同部位肿瘤浸润性淋巴细胞(tumoinfiltratinglymphocytes,TIL)的得率和成活率,以便制备TIL用于过继免疫治疗时正确切取标本。方法本实验对12例PHCC肿瘤组织不同部位TIL的得率和成活率进行了比较。结果肿瘤周围组织和肿瘤边缘组织TIL得率和成活率最高,肿瘤实质组织次之,肿瘤中心坏死组织最低,正常肝脏组织、腹水、胆管癌栓内几乎无TIL。结论制备PHCC组织TIL时,切取肿瘤周围组织和肿瘤边缘组织效果较好。 Objective To study the acquired number and activity of tumor infiltrating lymphocytes (TIL) from different places in primary hepatocellular carcinoma (PHCC) tissue. Methods The TILs acquired number and activity derived from different places of PHCC tissue in 12 cases were compared. Results The highest TILs acquired number and activity were gained from the superficial and peripheral tumor tissue; but the acquired number and activity were much lower in parenchyma tissue and center tissue of the tumor. There were almost no TILs in normal hepatic tissue, ascites and carcinomatous embolism of bile duct. Conclusions This study suggests that it be better to cut peripheral and superficial tumor tissue for gainings of TILs.
出处 《中国普通外科杂志》 CAS CSCD 1999年第2期133-134,共2页 China Journal of General Surgery
关键词 肝肿瘤 肝细胞癌 病理学 淋巴细胞 肿瘤浸润 LIVER NEOPLASMS/PA CARCINOMA, HEPATOCELLULAR/PA LYMPHOCYTES, TUMOR INFILTRATING
  • 相关文献

参考文献1

共引文献1

同被引文献39

  • 1王英,崔忠,李开宗,李玉松,秦亚东,王文勇,王剑波.肝细胞肝癌中p15基因产物的表达及其意义[J].中国普通外科杂志,2004,13(7):540-542. 被引量:3
  • 2陈罡,罗殿中,李萍,郭芳.原发性肝细胞癌、癌旁及肝硬化组织中CD3+细胞的研究[J].中国普通外科杂志,2005,14(2):142-145. 被引量:3
  • 3陈罡,罗殿中,李萍,郭芳.肝癌组织中B淋巴细胞的数量和分布及与临床的关系[J].广西医科大学学报,2005,22(2):217-219. 被引量:3
  • 4刘杰,章崇杰,何生,张平,魏大鹏,赵宗蓉,蔡美英.高效分离培养肿瘤浸润淋巴细胞方法的建立[J].华西医科大学学报,1996,27(1):36-39. 被引量:8
  • 5Eberl G, Lees R, Smiley ST, et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells [J]. J Immunology, 1999,162:6410-6419.
  • 6Norris S, Collins C, Doherty DG, et al. Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes [J]. Hepatology, 1998,28(1):84-96.
  • 7陈慰峰.医学免疫学[M](第四版)[M].北京:人民卫生出版社,2005.19-21.
  • 8Ratto GB.Zino P,Mirabelli S,et al.A randomized trial of adoptive immunotherapy with tunor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected non-small cell lung carcinoma[J]Cancer,1996,78(2) :244- 251.
  • 9Santin AD,Hermonat PL,Ravaggi A,et al .Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer[J] .Gynecol Obstet Invest,2001,51(4) :254- 261.
  • 10Santin AD,Ravaggi A,Bellone S,et al.Tumor-infiltrating 1ymphocytes contain higher numbers of type 1 cytokine expressors and DR + T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix[J] .Gynecol Oncol,2001,81(3) :424 - 432.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部